Conferences - Results from #9440

Viewing 9441-9460 of 11487 articles

ASCO GU 2017: Barriers in Progress in Muscle-Invasive and Non-muscle Invasive Bladder Cancer - Session Highlights

ASCO GU 2017: Keynote Lecture: Testicular Cancer - Session Highlights

ASCO GU 2017: Year in Review: Penile Cancer - Session Highlights

ASCO GU 2017: Urothelial Carcinoma: Year in Review - Session Highlights

ASCO GU 2017: Keynote Lecture, Emerging Impact of Genomics on the Clinical Management of Bladder Cancer - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Urologist View - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Medical Oncologist’s Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Surgeon’s Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Urologist Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Radiation Oncology Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Session Highlights

ASCO GU 2017: Best of Journals: Prostate Cancer - Medical Oncologist Perspective - Session Highlights

ASCO GU 2017: Best of Journals: Prostate Cancer - Radiation Oncologist Perspective - Session Highlights

ASCO GU 2017: Best of Journals: Prostate Cancer - Surgeon's Perspective - Session Highlights

ASCO GU 2017: Year in Review - Session Highlights

ASCO GU 2017: Individual patient level meta-analysis of the performance of the Decipher genomic classifier in high-risk men post-prostatectomy to predict development of metastatic disease. - Poster Session Highlights

ASCO GU 2017: Radium-223 (Ra-223) in asymptomatic metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP). - Poster Session Highlights

ASCO GU 2017: A clinical trial for the safety and immunogenicity of a DNA-based immunotherapy in men with biochemically (PSA) relapsed prostate cancer. - Poster Session Highlights

ASCO GU 2017: Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial. - Poster Session Highlights

ASCO GU 2017: Can focal therapy impact perioperative, oncological, and functional outcomes in men who underwent focal therapy salvage robotic-assisted radical prostatectomy? A retrospective matched-pair comparative study. - Poster Session Highlights

468
469
470
471
472
473
474
475
476
477